CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2025	Nov. 30, 2024	Aug. 31, 2025	Aug. 31, 2024
Operating Activities
Net (loss) earnings	$ 19,131	$ 21,723
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	4,448	3,514
Stock-based compensation expense	2,975	3,345
Provision for deferred income taxes	968	2,684
Amortization of debt issuance costs	147	147
Other Noncash Income (Expense)	33	46
Increase in Receivable Reserve	220	0
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	7,332	5,479
Inventories	(12,036)	(9,306)
Trade accounts payable	(1,158)	790
Prepaid expenses and other assets	(3,284)	(9,777)
Income tax accounts	3,387	422
Accrued compensation and benefits	(6,409)	(7,470)
Other accrued liabilities	222	(2,948)
Cash (Used in) Provided By Operating Activities	15,976	8,649
Investing Activities
Capital expenditures	(2,677)	(5,857)
Payments to Acquire Businesses, Net of Cash Acquired	0	27,196
Payment for Contingent Consideration Liability, Investing Activities	949	0
Cash Provided by Investing Activities	(3,626)	(33,053)
Financing Activities
Borrowings on Revolving Credit	0	14,421
Principal Repayment on Revolving Credit Facility	0	(14,421)
Principal repayments on term loan	(1,250)	(1,250)
Cash dividend	(2,119)	(2,167)
Cash used in financing activities	(23,497)	(12,783)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	(1,364)	826
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(12,511)	(36,361)
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	139,047	130,733	$ 151,558	$ 167,094
Payments for Repurchase of Common Stock	(14,899)	(4,379)
Stock options, taxes paid related to the net share settlement of equity awards and other	$ (5,229)	$ (4,987)